Objective: Antineoplastic drugs are considered high risk, and computerized systems favor safe administration. The objective of the study was to test the usefulness and safety of a new mobile device compared to the standard device for administering these antineoplastic treatments.
Data Sources: This multicenter, quasi-experimental pre-post study assessed an intervention in two cancer centers in June and July 2020.